These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37906702)

  • 1. Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation.
    Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
    J Chem Inf Model; 2023 Nov; 63(21):6487-6500. PubMed ID: 37906702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
    Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vismodegib Identified as a Novel COX-2 Inhibitor via Deep-Learning-Based Drug Repositioning and Molecular Docking Analysis.
    Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
    ACS Omega; 2023 Sep; 8(37):34160-34170. PubMed ID: 37744812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation.
    Wang Z; Sun L; Xu Y; Liang P; Xu K; Huang J
    J Transl Med; 2023 Aug; 21(1):579. PubMed ID: 37641144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation.
    Nayarisseri A; Khandelwal R; Madhavi M; Selvaraj C; Panwar U; Sharma K; Hussain T; Singh SK
    Curr Top Med Chem; 2020; 20(24):2146-2167. PubMed ID: 32621718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of machine learning models based on molecular fingerprints for selection of small molecule inhibitors against JAK2 protein.
    Belenahalli Shekarappa S; Kandagalla S; Lee J
    J Comput Chem; 2023 Jun; 44(16):1493-1504. PubMed ID: 36929511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering the Active Ingredients of Medicine and Food Homologous Substances for Inhibiting the Cyclooxygenase-2 Metabolic Pathway by Machine Learning Algorithms.
    Tian Y; Zhang Z; Yan A
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo design of dual-target JAK2, SMO inhibitors based on deep reinforcement learning, molecular docking and molecular dynamics simulations.
    He L; Liu J; Zhao HL; Zhang LC; Yu RL; Kang CM
    Biochem Biophys Res Commun; 2023 Jan; 638():23-27. PubMed ID: 36436338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repositioning of herbal compounds via a machine-learning approach.
    Kim E; Choi AS; Nam H
    BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation.
    Kong MM; Wei T; Liu B; Xi ZX; Ding JT; Liu X; Li K; Qin TL; Qian ZY; Wu WC; Wu JZ; Li WL
    Future Med Chem; 2024; 16(18):1821-1837. PubMed ID: 39145469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
    Hudson ML; Samudrala R
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Azevedo PHRA; Peçanha BRB; Flores-Junior LAP; Alves TF; Dias LRS; Muri EMF; Lima CHDS
    J Biomol Struct Dyn; 2024; 42(3):1417-1428. PubMed ID: 37054524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Checking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug Repurposing.
    Jamal S; Goyal S; Shanker A; Grover A
    PLoS One; 2015; 10(6):e0129370. PubMed ID: 26066505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new potential candidates to inhibit EGF via machine learning algorithm.
    Torabi M; Yasami-Khiabani S; Sardari S; Golkar M; Pérez-Sánchez H; Ghasemi F
    Eur J Pharmacol; 2024 Jan; 963():176176. PubMed ID: 38000720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Models Based on Molecular Fingerprints and an Extreme Gradient Boosting Method Lead to the Discovery of JAK2 Inhibitors.
    Yang M; Tao B; Chen C; Jia W; Sun S; Zhang T; Wang X
    J Chem Inf Model; 2019 Dec; 59(12):5002-5012. PubMed ID: 31746601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Dimensional Screening Strategy for Drug Repurposing with Statistical Framework-A New Road to Influenza Drug discovery.
    Rohini K; Ramanathan K; Shanthi V
    Cell Biochem Biophys; 2019 Dec; 77(4):319-333. PubMed ID: 31559538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing.
    Ouzounis S; Panagiotopoulos V; Bafiti V; Zoumpoulakis P; Cavouras D; Kalatzis I; Matsoukas MT; Katsila T
    OMICS; 2023 Jul; 27(7):305-314. PubMed ID: 37406257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gastrointestinal locally activating Janus kinase inhibitor to treat ulcerative colitis.
    Bu Y; Traore MDM; Zhang L; Wang L; Liu Z; Hu H; Wang M; Li C; Sun D
    J Biol Chem; 2023 Dec; 299(12):105467. PubMed ID: 37979913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel NLRP3 inhibitors as therapeutic options for epilepsy by machine learning-based virtual screening, molecular docking and biomolecular simulation studies.
    Zulfat M; Hakami MA; Hazazi A; Mahmood A; Khalid A; Alqurashi RS; Abdalla AN; Hu J; Wadood A; Huang X
    Heliyon; 2024 Aug; 10(15):e34410. PubMed ID: 39170440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D: an integrated machine learning and structure-based drug designing approach.
    Mahajan K; Verma H; Choudhary S; Raju B; Silakari O
    Mol Divers; 2021 Aug; 25(3):1617-1641. PubMed ID: 34272637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.